These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 23238695

  • 1. Clinical significance of ¹⁸F-fluorodeoxyglucose positron emission tomography in superficial esophageal squamous cell carcinoma.
    Kita Y, Okumura H, Uchikado Y, Sasaki K, Omoto I, Matsumoto M, Setoyama T, Tanoue K, Mori S, Owaki T, Ishigami S, Ueno S, Kajiya Y, Natsugoe S.
    Ann Surg Oncol; 2013 May; 20(5):1646-52. PubMed ID: 23238695
    [Abstract] [Full Text] [Related]

  • 2. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
    Furukawa T, Hamai Y, Hihara J, Emi M, Yamakita I, Ibuki Y, Okada M.
    Ann Surg Oncol; 2016 Nov; 23(12):4086-4092. PubMed ID: 27352201
    [Abstract] [Full Text] [Related]

  • 3. Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma.
    Toriyama K, Tajika M, Tanaka T, Ishihara M, Hirayama Y, Onishi S, Mizuno N, Kuwahara T, Okuno N, Matsumoto S, Sasaki E, Abe T, Yatabe Y, Hara K, Matsuo K, Tamaki T, Niwa Y.
    World J Gastroenterol; 2019 Dec 14; 25(46):6767-6780. PubMed ID: 31857778
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of venous invasion and maximum standardized uptake value of 18F-FDG PET/CT in surgically resected T1N0 esophageal squamous cell carcinoma.
    Jeon JH, Lee JM, Moon DH, Yang HC, Kim MS, Lee GK, Zo JI.
    Eur J Surg Oncol; 2017 Feb 14; 43(2):471-477. PubMed ID: 27912930
    [Abstract] [Full Text] [Related]

  • 5. Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma.
    Yasuda T, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, Doki Y.
    Ann Surg Oncol; 2015 Aug 14; 22(8):2599-607. PubMed ID: 25524011
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH, Choi JY, Shim YM, Kim K, Lee SJ, Cho YS, Lee JY, Lee KH, Kim BT.
    Ann Surg Oncol; 2010 Jan 14; 17(1):115-22. PubMed ID: 19826877
    [Abstract] [Full Text] [Related]

  • 7. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
    Choi JY, Jang HJ, Shim YM, Kim K, Lee KS, Lee KH, Choi Y, Choe YS, Kim BT.
    J Nucl Med; 2004 Nov 14; 45(11):1843-50. PubMed ID: 15534053
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of clinical significance of 18F-fluorodeoxyglucose positron emission tomography in superficial squamous cell carcinomas of the thoracic esophagus.
    Miyata H, Doki Y, Yasuda T, Yamasaki M, Higuchi I, Makari Y, Matsuyama J, Hirao T, Takiguchi S, Fujiwara Y, Monden M.
    Dis Esophagus; 2008 Nov 14; 21(2):144-50. PubMed ID: 18269650
    [Abstract] [Full Text] [Related]

  • 9. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
    Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, Tsukada K, Oriuchi N, Inoue T, Endo K.
    Cancer; 2002 Feb 15; 94(4):921-8. PubMed ID: 11920459
    [Abstract] [Full Text] [Related]

  • 10. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
    Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.
    Anticancer Res; 2003 Feb 15; 23(4):3263-72. PubMed ID: 12926062
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D, Yu J, Zhong X, Fu Z, Mu D, Zhang B, Xu G, Yang W, Zhao S.
    Dis Esophagus; 2012 Jul 15; 25(5):416-26. PubMed ID: 21951837
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma.
    Makino T, Doki Y, Miyata H, Yasuda T, Yamasaki M, Fujiwara Y, Takiguchi S, Higuchi I, Hatazawa J, Monden M.
    Surgery; 2008 Nov 15; 144(5):793-802. PubMed ID: 19081023
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Izumi D, Yoshida N, Watanabe M, Shiraishi S, Ishimoto T, Kosumi K, Tokunaga R, Taki K, Higashi T, Harada K, Miyata T, Ida S, Imamura Y, Iwagami S, Baba Y, Sakamoto Y, Miyamoto Y, Yamashita Y, Baba H.
    J Gastroenterol; 2016 Aug 15; 51(8):788-95. PubMed ID: 26671045
    [Abstract] [Full Text] [Related]

  • 16. Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.
    Schreurs LM, Smit JK, Pavlov K, Pultrum BB, Pruim J, Groen H, Hollema H, Plukker JT.
    Ann Surg Oncol; 2014 Nov 15; 21(12):3751-7. PubMed ID: 24939624
    [Abstract] [Full Text] [Related]

  • 17. F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma.
    Tanabe S, Naomoto Y, Shirakawa Y, Fujiwara Y, Sakurama K, Noma K, Takaoka M, Yamatsuji T, Hiraki T, Okumura Y, Mitani M, Kaji M, Kanazawa S, Fujiwara T.
    Clin Nucl Med; 2011 Oct 15; 36(10):854-9. PubMed ID: 21892033
    [Abstract] [Full Text] [Related]

  • 18. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
    Higuchi I, Yasuda T, Yano M, Doki Y, Miyata H, Tatsumi M, Fukunaga H, Takiguchi S, Fujiwara Y, Hatazawa J, Monden M.
    J Thorac Cardiovasc Surg; 2008 Jul 15; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
    [Abstract] [Full Text] [Related]

  • 19. Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma.
    Hsu WH, Hsu PK, Wang SJ, Lin KH, Huang CS, Hsieh CC, Wu YC.
    Ann Thorac Surg; 2009 May 15; 87(5):1564-8. PubMed ID: 19379906
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.